About the Editors


Sobha Sivaprasad, MBBS, DM, FRCS, FRCOphth, Moorfields Eye Hospital; University College London, UK

Dr Sivaprasad is a Consultant Ophthalmologist at NIHR Moorfields Biomedical Research Centre, London, UK. She completed her Medical Retina Fellowship from Moorfields Eye Hospital. Her higher research degree from Cranfield University and King's College Hospital is on ‘Co-morbidity of age related macular degeneration and atherosclerosis’.
Dr Sivaprasad has active clinical and laboratory research interests in age related macular degeneration, diabetic retinopathy and retinal vascular disorders. Her research focuses on biomarkers and modeling of retinal morphology in retinal diseases.
She also runs several clinical trials in these areas and has over 100 peer reviewed publications to her credit.

Associate Editors

Winfried Amoaku, FRCSEd, FRCOphth, PhD, AFHEA, Nottingham University Hospitals NHS Trust; University of Nottingham, UK

Tin Aung - Singapore National Eye Centre, Singapore

MBBS (Singapore), FRCS(Ed), FRCOphth (UK), MMed (Ophth) (Singapore), FAM (Singapore), PhD (London)
Professor Aung is currently:
1. Executive Director, Singapore Eye Research Institute;
2. Deputy Medical Director (Research) and Head, Glaucoma Department, Singapore National Eye Centre;
3. Professor, Department of Ophthalmology, Yong Loo Lin School of Medicine, National University of Singapore

Professor Aung is a clinician scientist, with clinical practice focusing on glaucoma and research interests in angle closure glaucoma and glaucoma genetics. With >450 publications, Professor Aung has been awarded >US$20 million in competitive research grant funding. He has received numerous awards including the Singapore Translational Research (STaR) Investigator Award in 2014, the Singapore National Medical Research Council-Clinician Scientist Awards in 2005 and 2008, the President's Science Award in 2009, the Nakajima (2007) and De Campo Awards (2013) from the Asia Pacific Academy of Ophthalmology and the Alcon Research Institute Award in 2013.
Professor Aung is a member of the Editorial Boards of Ophthalmology, Journal of Glaucoma, Eye, Graefe's Archive for Clinical and Experimental Ophthalmology, and 6 other journals. He is currently President of the World Glaucoma Association and also serves as a Board member of the Asia-Pacific Glaucoma Society and the Asian Angle Closure Glaucoma Club.

Rupert Bourne, BSc, FRCOphth, MB, BS, MD, Cambridge University Hospital; Vision & Eye Research Institute, Anglia Ruskin University, UK

Rupert Bourne is Professor of Ophthalmology at Anglia Ruskin University, Cambridge and Consultant Ophthalmic Surgeon at Cambridge University Hospital, where he directs the Cambridge Eye Research Centre. He trained at Moorfields Eye Hospital and undertook two Glaucoma fellowships, one there and another at the Shiley Eye Centre/Hamilton Glaucoma Center in San Diego, California. He has a strong research interest, particularly in advanced techniques of Glaucoma diagnosis and progression and the management of Glaucoma in the community, along with overseas ophthalmology which has involved design and analysis of several large population-based surveys of eye disease, several national in scope, eg. Pakistan, Bangladesh and Trinidad. He is the Chair of the National Institute for Health Research Ophthalmology Specialty Group, responsible for NHS research delivery. In his role as Coordinator of the Vision Loss Expert Group of the Global Burden of Disease Study, he has overseen the long-term research into the world-wide prevalence rates of blindness and visual impairment, in partnership with the World Health Organization. He is Chief Investigator for the UK National Eye Health and Hearing Study due to start in 2020.

Christopher Brand, MBChB, FRCOphth, Sheffield Teaching Hospitals NHS Foundation Trust, UK

Ahmet Kaan Gündüz, MD, Ankara University; Private Gündüz Eye Clinic, Turkey

Parwez Hossain - Southampton University, Southampton, UK

Parwez Hossain is King James IV Professor of Surgery (Royal College of Surgeons, Edinburgh) and Associate Professor in Ophthalmology at the University of Southampton. He qualified in Medicine from Aberdeen University and trained in Ophthalmology in Aberdeen, Nottingham, Leicester & Bascom Palmer Eye Institute, Miami, USA. He sub-specializes in Cornea & External Eye Disease, and is head of the corneal service for the Southampton Eye Unit, Southampton University Hospital NHS Foundation Trust, takes care of a diverse range of corneal diseases with patients coming from different regions of the UK.

Parwez's clinician-scientist career started as Wellcome Trust Fellow at Aberdeen University where he studied the mechanisms of lymphocyte traffic in ocular inflammation. In his PhD thesis, he established a novel method for in vivo tracking of immune cells in the posterior segment of the eye. The technique allowed the observation of lymphocytes and inflamed vascular endothelium, in real-time. Following his PhD, Parwez moved to Nottingham University, where, as a Clinical Lecturer, his interest focused on investigating the innate immune mechanisms in corneal inflammation. He determined that the immune adhesion molecule CD34 is a unique marker for human corneal stromal keratocytes (corneal fibroblast) activation. Whilst at Nottingham, he also helped to establish the effectiveness of a new surgical technique called 'Fine Needle Diathermy' to treat long standing corneal vascularization. This treatment helps against chronic corneal vascularization and can restore vision in patients with vascularisation from herpes keratitis or chronic corneal graft rejection. Parwez also developed techniques in corneal confocal imaging and his work has highlighted the benefit of this in the early detection of diabetic peripheral neuropathy (published in The Lancet).

After his fellowship training period, Parwez moved to Southampton, to start a research programme in corneal infection. In his current role, he leads a corneal infection research group comprising a post-doctoral fellow, PhD & undergraduate research students. His research focus is to develop new diagnostic techniques for the rapid diagnosis and monitoring of corneal infections. His group have developed technologies such as anterior segment OCT & microfluidic impedance cytometry to allow rapid microbial diagnostic detection/monitoring. With collaboration with his surgical colleagues in Southampton, Parwez has developed an active surgical research programme with the aim to develop optimal surgical methods for corneal diseases. Developing method such as ultrathin DSEK and accelerated protocols for collagen cross-linking for Keratoconus. His surgical team are part of the UK Collagen Cross-linking Consortium and are major providers for collagen crosslinking therapy for the South Coast of the UK. In 2018, Parwez was awarded King James IV Professor in Surgery by The Royal College of Surgeons, Edinburgh for his sustained research in the development of real-time diagnostic methods/devices in Ophthalmology.

His work has been supported by research grants from the Royal College of Surgeons of Edinburgh, the British Council for the Prevention for Blindness, National Eye Research Centre, Engineering & Physicals Sciences Research Council (UK) and Medical Research Council (UK).

Anthony Khawaja, MA(Cantab), MBBS, PhD, FRCOphth, Moorfields Eye Hospital NHS Foundation Trust; University College London, UK

Anthony Khawaja is Associate Professor at the UCL Institute of Ophthalmology and Honorary Consultant Ophthalmic Surgeon at Moorfields Eye Hospital, London. He is currently a UK Research & Innovation Future Leaders Fellow. Anthony completed his medical training at the University of Cambridge and University College London and has undertaken the majority of his ophthalmic residency training at Moorfields Eye Hospital. His research training began with a Wellcome Trust funded PhD programme at the University of Cambridge, including a Masters in Epidemiology for which he won the Nick Day Prize. He was also awarded the Berkeley Fellowship which supported a research period at Harvard Medical School.

Anthony’s research interests concern the genetic and environmental epidemiology of glaucoma, and learning about disease pathogenesis and optimal care pathways by probing routinely collected data. His ultimate aim is to develop clinical tools to personalise screening and treatment of glaucoma. Anthony is an active member of international multidisciplinary consortia for eye diseases, including the International Glaucoma Genetics Consortium and the European Eye Epidemiology consortium. Anthony established the Young Ophthalmologists section of the European Society of Ophthalmology and is director for the European Leadership Development Programme. He was recently voted in The Ophthalmologist's top 100 most influential thought leaders in ophthalmology globally. Anthony is chair of the Royal College of Ophthalmologists Informatics sub-committee.

Timothy Lai, MD, FRCOphth, FRCS, The Chinese University of Hong Kong, Hong Kong, China

Dr Lai is an Honorary Clinical Associate Professor of the Department of Ophthalmology & Visual Sciences, The Chinese University of Hong Kong, and Director of 2010 Retina and Macula Centre, Hong Kong. His clinical and research interests lie in the medical and surgical management of retinal diseases, particularly polypoidal choroidal vasculopathy, choroidal neovascularization, central serous chorioretinopathy, myopic maculopathy, diabetic retinopathy; visual electrophysiology; and genetics of retinal diseases and uveitis. He has extensive experience in the conduct of clinical trials and is the principle investigator of over 15 industry-sponsored Phase II, III and IV clinical trials.

As one of the leading experts in vitreo-retinal diseases in the Asia-Pacific region, Dr Lai has published more than 180 papers in international peer-reviewed journals and co-authored and edited 10 textbooks. He has also delivered over 120 invited lectures worldwide and has received a number of 

Andrew Lee, MD, Blanton Eye Institute, Houston Methodist Hospital; Weill Cornell Medicine, USA

Andrew G Lee, M.D. is an honors graduate of the University of Virginia undergraduate school and an Alpha Omega Alpha graduate of the UVA School of Medicine. He completed his ophthalmology residency and was the chief resident at Baylor College of Medicine in Houston, Texas in 1993. Following eye residency, Dr Lee completed a clinical fellowship in neuro-ophthalmology with Neil R. Miller MD at the Wilmer Eye Institute and was a post-doctoral Fight for Sight research fellow at the Johns Hopkins Hospital in Baltimore, Maryland from 1993-1994. He was an Associate Professor at Baylor College of Medicine and Adjunct Associate Professor at the M.D. Anderson Cancer Center in Houston from 1994-2000. From 2000-2008, Dr Lee was Professor of Ophthalmology, Neurology, and Neurosurgery in the H. Stanley Thompson Neuro-ophthalmology Clinic at the University of Iowa Hospitals and Clinics. In April 2009 Dr Lee assumed the chairmanship of ophthalmology at The Blanton Eye Institute, at Houston Methodist Hospital in Texas and was appointed Professor of Ophthalmology, Neurological Surgery and Neurology at Weill Cornell Medical College.
Dr Lee has published over 260 peer-reviewed articles, 40 book chapters, and three full textbooks in ophthalmology. He serves on the Editorial Board of 12 journals including the American Journal of Ophthalmology, the Canadian Journal of Ophthalmology, and Eye. He has received the American Academy of Ophthalmology (AAO) Honor Award, the AAO Secretariat Award, and the AAO Senior Achievement Award. Dr Lee has been the invited guest speaker at over 140 national and international eye meetings.
Dr Lee’s area of research interest is in optic nerve disease. He was the Director of New Educational Initiatives in the Graduate Medical Education (GME) office at Iowa and has published extensively in the area of resident graduate medical education. In April 2009 Dr Lee assumed the chairmanship of ophthalmology at The Methodist Hospital in Houston, Texas and was appointed Professor of Ophthalmology, Neurological Surgery and Neurology at Weill Cornell Medical College.

Caroline MacEwen, MD, FRCS, FRCOphth, University of Dundee, UK

Caroline (Carrie) MacEwen is a Consultant Ophthalmologist at Ninewells Hospital and Medical School and Head of the Ophthalmology Department at the University of Dundee (Honorary Professor). She trained in Glasgow, Dundee and London. Her clinical interests lie in the field of strabismus and ocular motility after carrying out her subspecialty training at Moorfields Eye Hospital under the guidance of John Lee. Research interests include paediatric naso -lacrimal disease, trauma, sports medicine, epidemiology and clinical research on strabismus management. She has been a member of the British Ophthalmic Surveillance Unit (BOSU) committee since its inception. International and national awards for her work include the Gregg medal for ‘contribution to medical science’, the Founder's Cup, Ian Fraser trophy, Spencer Walker prize and Foulds' trophy. She has published more than 150 papers, written or edited 3 textbooks and written 17 book chapters. Carrie is an associate postgraduate Dean in the East of Scotland.
She is Chair of the Academy of Medical Royal Colleges (2017–2020) and was President of the Royal College of Ophthalmologists (2014 – 2017). She represented the RCOphth in the development of the Faculty of Sport and Exercise Medicine (FSEM)
She is ophthalmology clinical co-lead for the Getting It Right First Time (GIRFT) project, was a member of the Right Care Clinical Improvement Group and chaired the Elective Care Transformation Ophthalmology Working Group.
She is Ophthalmology Specialty Adviser to the Scottish Government and leads the National Ophthalmology Workstream in Scotland and is a member of the National Access Collaborative. Professor MacEwen chaired the Scottish update of Certification of Vision Impairment and was a member of the UKCVI development board, the UK Vision Strategy Leadership Group and Transition Programme Board.
Carrie has worked nationally with all eye health care professionals to share and develop new ways of delivering ophthalmic care and has delivered a framework to support this.  She has been made an honorary fellow of the College of Optometrists and the British and Irish Orthoptic Society, the Faculty of Sport and Exercise Medicine and the Royal College of Physicians, Edinburgh

Hunter MacLean, MBChB, FRCS(edin), FRCOphth, Portsmouth Hospitals University Trust, UK

Hunter Maclean is a Consultant Ophthalmologist at the Queen Alexandra Eye Hospital Portsmouth, in the south of England. He specialises in oculoplastics and lacrimal surgery. He received his medical degree from Edinburgh University and did further training there and at Newcastle with a fellowship in Sydney, Australia before taking up his consultant post in 1998. He was a founding member of the British Oculoplastic surgical society and takes an active part in research within the department and is also the current President of the Southern Ophthalmological Society. He has written one book and contributed several chapters in others. He was appointed Associate Editor of Eye in 2009.

Saaeha Rauz - University of Birmingham, Birmingham and Midland Eye Centre, Birmingham, UK

Dr Rauz is a clinical academic who has a specialist interest in complex, blinding immune-mediated ocular surface diseases at the University of Birmingham (UK) and the Birmingham & Midland Eye Centre, Birmingham (UK). She has an expertise in rare progressive conjunctival scarring disorders such as mucous membrane pemphigoid and Stevens-Johnson Syndrome / Toxic Epidermal Necrolysis together with secondary causes of inflammatory dry eye disease including Primary Sjögren’s Syndrome and Atopic Keratoconjunctivitis.
A Bedside-to-Bench-to-Bedside approach underpins her research portfolio, with patients pivotal for informing research directions. Key areas of research include (i) evaluating drivers of ocular surface inflammation and scarring, (ii) monitoring and measuring outcomes and (iii) translating technologies that modify biological processes.
The ultimate aim of her clinical and research portfolio is to improve disabling signs and symptoms that impact upon patient wellbeing and quality of life.

Federico Ricci, MD, University of Rome Tor Vergata, Italy

Federico Ricci is Associate Professor in Ophthalmology at the University of Tor Vergata of Rome (Italy), Department of Experimental Medicine. He received his Medicine degree from University la Sapienza of Rome and trained in Ophthalmology from the same University. He is the past president of Italian Retina Society and is an active member of the Italian Ophthalmological Society executive board. He is a member of CNIT (National Inter-University Consortium for Telecommunications) and is involved in projects of telemedicine and AI applications in Ophthalmology. Since 2006 he has been an “expert consultant” for AIFA (Italian Medicines Agency). Professor Ricci is the Director of "Retina Diseases Unit" at PTV Foundation Hospital of Rome. The Unit is a Regional Referral Centre and Clinical Trial Centre for AMD and blinding retinal diseases. His basic science and clinical and research interests are focused on angiogenesis in eye diseases and on management of degenerative and inherited retinal diseases. He has extensive experience in registration clinical trials and, since 2008, has been the principal investigator of over 40 trials.

Rupal Trivedi, MBBS, MSurg, MSCR, Medicial Univeristy of South Carolina, USA

Dr Trivedi is a Research Associate Professor at Storm Eye Institute, Medical University of South Carolina, USA. She completed her residency in Ophthalmology from India in 1995. From 1995 to 2000, she worked at Iladevi cataract and IOL research center, India. She received her Master of Science in Clinical Research (MSCR) degree from Medical University of South Carolina. Dr Trivedi's research interests include cataract surgery, especially for children. She has published more than 100 articles in peer-reviewed journals and presented her research work at various national and international meetings. She is recipient of various awards including ASCRS foundation Binkhorst young ophthalmologist award, American Academy of Ophthalmology Achievement Award, RCMAR scholar award and Clinical Research Curriculum Award. 

Managing Editor

Steve Beet, UK